Topical vitamin D3 derivatives for recalcitrant warts in three immunocompromised patients [7]

British Journal of Dermatology

Volumn 150, Issue 2, 2004, Pages 374-376

  Egawa, K ^a   Ono, T ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; CALCIPOTRIOL; CIMETIDINE; COLECALCIFEROL DERIVATIVE; GLUTARALDEHYDE; ANTIVIRUS AGENT; COLECALCIFEROL;

ADULT; CASE REPORT; CROHN DISEASE; ELECTROCOAGULATION; FEMALE; HUMAN; IMMUNE DEFICIENCY; LETTER; MALE; PRIORITY JOURNAL; PROTECTIVE CLOTHING; VERRUCA VULGARIS; WART VIRUS; HAND DISEASE; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANTIVIRAL AGENTS; CHOLECALCIFEROL; FEMALE; HAND DERMATOSES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; WARTS;

EID: 1542611388     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05766.x     Document Type: Letter

References (9)

1. Sterling JC, Kurtz JB. Viral infection. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA, Breathnach SM, eds), 6th edn. Vol. 2. Oxford: Blackwell Science Ltd, 1998; 995-1096.
2. Sterling JC, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol 2001; 144: 4-11.
3. Gross GE, Barrasso R. General principles of treatment. In: Human Papilloma Virus Infection: A Clinical Atlas (Gross GE, Barraso R, eds). Berlin, Wiesbaden: Ullstein Mosby, 1997; 47-62.
4. Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review. Br Med J 2002; 325: 461-4.
5. Barker JNWN, Ashton RE, Marks R et al. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator. Br J Dermatol 1999; 141: 274-8.
6. Mason J, Mason AR, Cork MJ. Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol 2002; 146: 351-64.
7. Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol 2002; 147: 197-213.
8. 3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effect of retinoids. Cancer Lett 1995; 89: 117-24.
9. Majewski S, Skopinska M, Bollag W, Jablonska S. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet 1994; 344: 1510-1.